Published in Cancer Res on September 01, 2005
Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment. Annu Rev Pathol (2009) 1.88
Molecular biology of squamous cell carcinoma of the head and neck. J Clin Pathol (2006) 1.76
Diagnostic aids in the screening of oral cancer. Head Neck Oncol (2009) 1.64
New hope for an oral cancer solution: together we can make a difference. J Can Dent Assoc (2008) 1.55
NQO1-activated phenothiazinium redox cyclers for the targeted bioreductive induction of cancer cell apoptosis. Free Radic Biol Med (2007) 1.16
Tracing the "at-risk" oral mucosa field with autofluorescence: steps toward clinical impact. Cancer Prev Res (Phila) (2009) 1.12
Oral potentially malignant disorders: is malignant transformation predictable and preventable? Med Oral Patol Oral Cir Bucal (2014) 1.10
Oral premalignancy: new methods of detection and treatment. Curr Oncol Rep (2006) 1.09
Potential of optical coherence tomography for early diagnosis of oral malignancies. Expert Rev Anticancer Ther (2010) 1.08
Salivary markers for oral cancer detection. Open Dent J (2010) 1.03
Squamous cell carcinoma and precursor lesions: diagnosis and screening in a technical era. Periodontol 2000 (2011) 0.99
A dynamic oral cancer field: unraveling the underlying biology and its clinical implication. Am J Surg Pathol (2009) 0.97
The usefulness of toluidine staining as a diagnostic tool for precancerous and cancerous oropharyngeal and oral cavity lesions. Acta Otorhinolaryngol Ital (2009) 0.96
A comparative analysis of toluidine blue with frozen section in oral squamous cell carcinoma. World J Surg Oncol (2012) 0.91
Improving oral cancer survival: the role of dental providers. J Calif Dent Assoc (2009) 0.89
A brief review of common oral premalignant lesions with emphasis on their management and cancer prevention. Indian J Surg (2011) 0.89
Oral squamous cell carcinoma in relation to field precancerisation: pathobiology. Cancer Cell Int (2013) 0.87
Epithelial dysplasia in oral cavity. Iran J Med Sci (2014) 0.87
Toluidine blue color perception in identification of oral mucosal lesions. Clin Oral Investig (2010) 0.85
Diagnostic accuracy of diffuse reflectance imaging for early detection of pre-malignant and malignant changes in the oral cavity: a feasibility study. BMC Cancer (2013) 0.83
Optical molecular imaging detects changes in extracellular pH with the development of head and neck cancer. Int J Cancer (2012) 0.83
Will the mininvasive approach challenge the old paradigms in oral cancer surgery? Eur Arch Otorhinolaryngol (2016) 0.79
Validation of LOH profiles for assessing oral cancer risk. Cancer Prev Res (Phila) (2012) 0.78
Targeting of chemoprevention to high-risk potentially malignant oral lesions: challenges and opportunities. Oral Oncol (2014) 0.76
Cell transformation and the evolution of a field of precancerization as it relates to oral leukoplakia. Int J Dent (2011) 0.75
Diagnostic modalities for squamous cell carcinoma: an extensive review of literature-considering toluidine blue as a useful adjunct. J Maxillofac Oral Surg (2014) 0.75
Adjunctive aids for the detection of oral premalignancy. J Pharm Bioallied Sci (2016) 0.75
Intraoperative assessment of surgical margins of oral squamous cell carcinoma using frozen sections: a practical clinicopathological management for recurrences. Biomed Res Int (2014) 0.75
Chemiluminescence and Toluidine Blue as Diagnostic Tools for Detecting Early Stages of Oral Cancer: An invivo Study. J Clin Diagn Res (2014) 0.75
High-resolution optical molecular imaging of changes in choline metabolism in oral neoplasia. Transl Oncol (2013) 0.75
Toluidine Blue Staining in Identification of a Biopsy Site in Potentially Malignant Lesions: A Case-control Study. Asia Pac J Oncol Nurs (2017) 0.75
Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet (2005) 15.37
Mammographic density and the risk and detection of breast cancer. N Engl J Med (2007) 14.32
A comprehensive analysis of common copy-number variations in the human genome. Am J Hum Genet (2006) 8.61
A tiling resolution DNA microarray with complete coverage of the human genome. Nat Genet (2004) 7.68
The functional role of long non-coding RNA in human carcinomas. Mol Cancer (2011) 6.37
Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet (2010) 4.51
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet (2010) 3.86
Adjunctive techniques for oral cancer examination and lesion diagnosis: a systematic review of the literature. J Am Dent Assoc (2008) 3.74
Resolving the resolution of array CGH. Genomics (2007) 3.66
Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol (2003) 3.46
PIK3CA mutations and copy number gains in human lung cancers. Cancer Res (2008) 3.42
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet (2013) 3.42
Loss of heterozygosity (LOH) profiles--validated risk predictors for progression to oral cancer. Cancer Prev Res (Phila) (2012) 3.03
Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer (2007) 2.95
Carcinogenic and endocrine disrupting effects of cigarette smoke and risk of breast cancer. Lancet (2002) 2.79
Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines. PLoS One (2009) 2.79
Fluorescence visualization detection of field alterations in tumor margins of oral cancer patients. Clin Cancer Res (2006) 2.73
Simple device for the direct visualization of oral-cavity tissue fluorescence. J Biomed Opt (2006) 2.58
Integrating copy number polymorphisms into array CGH analysis using a robust HMM. Bioinformatics (2006) 2.50
Multiple microalterations detected at high frequency in oral cancer. Cancer Res (2005) 2.47
Body size, mammographic density, and breast cancer risk. Cancer Epidemiol Biomarkers Prev (2006) 2.44
Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2007) 2.40
Human cancer long non-coding RNA transcriptomes. PLoS One (2011) 2.38
Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies. Lancet Oncol (2013) 2.32
High resolution analysis of non-small cell lung cancer cell lines by whole genome tiling path array CGH. Int J Cancer (2006) 2.16
Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression. Genome Res (2012) 2.10
The connection between human papillomavirus and oropharyngeal squamous cell carcinomas in the United States: implications for dentistry. J Am Dent Assoc (2011) 2.10
The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing. Clin Cancer Res (2011) 2.09
A stepwise framework for the normalization of array CGH data. BMC Bioinformatics (2005) 2.08
SeeGH--a software tool for visualization of whole genome array comparative genomic hybridization data. BMC Bioinformatics (2004) 2.04
Comprehensive copy number profiles of breast cancer cell model genomes. Breast Cancer Res (2006) 2.02
Oncogene mutations, copy number gains and mutant allele specific imbalance (MASI) frequently occur together in tumor cells. PLoS One (2009) 1.94
Lung cancer cell lines as tools for biomedical discovery and research. J Natl Cancer Inst (2010) 1.92
Mammographic density as a surrogate marker for the effects of hormone therapy on risk of breast cancer. Cancer Epidemiol Biomarkers Prev (2006) 1.91
Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities. Support Care Cancer (2011) 1.78
Organochlorines and risk of non-Hodgkin lymphoma. Int J Cancer (2007) 1.78
Patient-derived first generation xenografts of non-small cell lung cancers: promising tools for predicting drug responses for personalized chemotherapy. Clin Cancer Res (2010) 1.77
3p14 and 9p21 loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites. Cancer Res (2002) 1.75
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun (2013) 1.73
EZH2 promotes E2F-driven SCLC tumorigenesis through modulation of apoptosis and cell-cycle regulation. J Thorac Oncol (2013) 1.72
Recent advances in array comparative genomic hybridization technologies and their applications in human genetics. Eur J Hum Genet (2006) 1.61
Chromosome-wide DNA methylation analysis predicts human tissue-specific X inactivation. Hum Genet (2011) 1.60
Direct fluorescence visualization of clinically occult high-risk oral premalignant disease using a simple hand-held device. Head Neck (2007) 1.58
New hope for an oral cancer solution: together we can make a difference. J Can Dent Assoc (2008) 1.55
Acquired resistance to EGFR inhibitors is associated with a manifestation of stem cell-like properties in cancer cells. Cancer Res (2013) 1.54
Microarrays and clinical dentistry. J Am Dent Assoc (2003) 1.53
Modeling recurrent DNA copy number alterations in array CGH data. Bioinformatics (2007) 1.52
Comparison of toxicity associated with early morning versus late afternoon radiotherapy in patients with head-and-neck cancer: a prospective randomized trial of the National Cancer Institute of Canada Clinical Trials Group (HN3). Int J Radiat Oncol Biol Phys (2008) 1.52
Oral submucous fibrosis, a clinically benign but potentially malignant disease: report of 3 cases and review of the literature. J Can Dent Assoc (2008) 1.50
Effect of active smoking on the human bronchial epithelium transcriptome. BMC Genomics (2007) 1.50
Genetic alteration and gene expression modulation during cancer progression. Mol Cancer (2004) 1.50
Defining clinically meaningful outcomes in the evaluation of new treatments for oral mucositis: oral mucositis patient provider advisory board. Cancer Invest (2002) 1.49
MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors. Int J Cancer (2009) 1.48
Physical and functional interaction between the varicella zoster virus IE63 and IE62 proteins. Virology (2002) 1.47
The ins and outs of change of shift handoffs between nurses: a communication challenge. BMJ Qual Saf (2012) 1.43
Radiographic and clinical features of temporomandibular dysfunction in patients following indirect trauma: a retrospective study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2007) 1.42
TRAF6 is an amplified oncogene bridging the RAS and NF-κB pathways in human lung cancer. J Clin Invest (2011) 1.42
Epigenomics: mapping the methylome. Cell Cycle (2006) 1.42
Influence of fluorescence on screening decisions for oral mucosal lesions in community dental practices. J Oral Pathol Med (2013) 1.41
Burning mouth syndrome. Am Fam Physician (2002) 1.40
Integrative genomic analyses identify BRF2 as a novel lineage-specific oncogene in lung squamous cell carcinoma. PLoS Med (2010) 1.38
Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer. Oncotarget (2014) 1.38
Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nat Commun (2013) 1.36
Genome-wide identification of human microRNAs located in leukemia-associated genomic alterations. Blood (2010) 1.36
High-resolution array CGH increases heterogeneity tolerance in the analysis of clinical samples. Genomics (2005) 1.35
Array CGH technologies and their applications to cancer genomes. Chromosome Res (2005) 1.33
Bleeding disorders of importance in dental care and related patient management. J Can Dent Assoc (2007) 1.32
A randomized trial of dietary intervention for breast cancer prevention. Cancer Res (2011) 1.32
Multiple aberrations of chromosome 3p detected in oral premalignant lesions. Cancer Prev Res (Phila) (2008) 1.30
DNA extraction from paraffin embedded material for genetic and epigenetic analyses. J Vis Exp (2011) 1.27
Comprehensive whole genome array CGH profiling of mantle cell lymphoma model genomes. Hum Mol Genet (2004) 1.27
Proliferative verrucous leukoplakia and its progression to oral carcinoma: a review of the literature. J Oral Pathol Med (2007) 1.26
Promoter sequences of varicella-zoster virus glycoprotein I targeted by cellular transactivating factors Sp1 and USF determine virulence in skin and T cells in SCIDhu mice in vivo. J Virol (2003) 1.25
Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes. Gastroenterology (2007) 1.25
A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study group. Support Care Cancer (2010) 1.25
Mucositis-related morbidity and resource utilization in head and neck cancer patients receiving radiation therapy with or without chemotherapy. J Pain Symptom Manage (2009) 1.25
Advanced vertebral fracture among newly diagnosed children with acute lymphoblastic leukemia: results of the Canadian Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) research program. J Bone Miner Res (2009) 1.24
Copy number alterations of c-MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy. Cancer (2012) 1.23
Oral and dental management related to radiation therapy for head and neck cancer. J Can Dent Assoc (2003) 1.23
Cytogenetically balanced translocations are associated with focal copy number alterations. Hum Genet (2006) 1.23
Oral adverse events associated with tyrosine kinase and mammalian target of rapamycin inhibitors in renal cell carcinoma: a structured literature review. Oncologist (2011) 1.22
Carcinoma of the tongue: a case series analysis of clinical presentation, risk factors, staging, and outcome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2004) 1.22
Burning mouth syndrome: recognition, understanding, and management. Oral Maxillofac Surg Clin North Am (2008) 1.22
Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers. PLoS One (2011) 1.20
Methods for high throughput validation of amplified fragment pools of BAC DNA for constructing high resolution CGH arrays. BMC Genomics (2004) 1.19
Epigenetics of cancer progression. Pharmacogenomics (2008) 1.18